,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1758419,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55259,DNAI7,https://ctdbase.org/detail.go?type=gene&acc=55259,,,55259,DNAI7,10141,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DNAI7 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
1,1758420,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3301,DNAJA1,https://ctdbase.org/detail.go?type=gene&acc=3301,,,3301,DNAJA1,10141,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DNAJA1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
2,1758421,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10294,DNAJA2,https://ctdbase.org/detail.go?type=gene&acc=10294,,,10294,DNAJA2,10141,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DNAJA2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
3,1758422,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55466,DNAJA4,https://ctdbase.org/detail.go?type=gene&acc=55466,,,55466,DNAJA4,10116,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DNAJA4 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
4,1758423,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337,DNAJB1,10141,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DNAJB1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
5,1758424,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337,DNAJB1,10116,Rattus norvegicus (Norway rat),Thioacetamide results in increased methylation of DNAJB1 promoter,,,PMID:27914986,https://www.ncbi.nlm.nih.gov/pubmed/27914986,27914986,,
6,1758124,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1213,CLTC,https://ctdbase.org/detail.go?type=gene&acc=1213,,,1213,CLTC,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CLTC mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
7,1758125,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499,CTNNB1,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CTNNB1 mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
8,1758126,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508,CTSB,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CTSB mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
9,1758127,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509,CTSD,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CTSD mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
10,1758128,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1514,CTSL,https://ctdbase.org/detail.go?type=gene&acc=1514,,,1514,CTSL,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CTSL mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
11,1758129,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,1520,CTSS,https://ctdbase.org/detail.go?type=gene&acc=1520,,,1520,CTSS,10090,Mus musculus (house mouse),Fumonisin B1 results in increased expression of CTSS mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
12,1758130,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919,CXCL1,9606,Homo sapiens (human),Fumonisin B1 results in decreased expression of CXCL1 mRNA,,,PMID:27757495,https://www.ncbi.nlm.nih.gov/pubmed/27757495,27757495,,
13,1758131,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,6373,CXCL11,https://ctdbase.org/detail.go?type=gene&acc=6373,,,6373,CXCL11,9606,Homo sapiens (human),Fumonisin B1 results in increased expression of CXCL11 mRNA,,,PMID:27757495,https://www.ncbi.nlm.nih.gov/pubmed/27757495,27757495,,
14,1758132,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin b1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387,CXCL12,10090,Mus musculus (house mouse),Fumonisin B1 results in decreased expression of CXCL12 mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
15,1758425,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5095,PCCA,https://ctdbase.org/detail.go?type=gene&acc=5095,,,5095,PCCA,10116,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of PCCA mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
16,1758426,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575,PCDH10,9606,Homo sapiens (human),Cobaltous chloride results in decreased expression of PCDH10 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
17,1758427,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,5098,PCDHGC3,https://ctdbase.org/detail.go?type=gene&acc=5098,,,5098,PCDHGC3,9606,Homo sapiens (human),Cobaltous chloride results in increased expression of PCDHGC3 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
18,1758428,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,63935,PCIF1,https://ctdbase.org/detail.go?type=gene&acc=63935,,,63935,PCIF1,9606,Homo sapiens (human),Cobaltous chloride affects the expression of PCIF1 mRNA alternative form,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
19,1758429,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,63935,PCIF1,https://ctdbase.org/detail.go?type=gene&acc=63935,,,63935,PCIF1,9606,Homo sapiens (human),Cobaltous chloride results in decreased expression of PCIF1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
20,1758557,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528,DAZAP1,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAZAP1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
21,1758558,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528,DAZAP1,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
22,1758682,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1630,DCC,https://ctdbase.org/detail.go?type=gene&acc=1630,,,1630,DCC,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCC mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
23,1758757,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,117159,DCD,https://ctdbase.org/detail.go?type=gene&acc=117159,,,117159,DCD,9606,Homo sapiens (human),"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of DCD protein",,,PMID:25670856,https://www.ncbi.nlm.nih.gov/pubmed/25670856,25670856,,
24,1758758,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,341019,DCDC1,https://ctdbase.org/detail.go?type=gene&acc=341019,,,341019,DCDC1,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCDC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
25,1758759,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,8642,DCHS1,https://ctdbase.org/detail.go?type=gene&acc=8642,,,8642,DCHS1,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCHS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
26,1758760,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201,DCLK1,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
27,1758761,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,166614,DCLK2,https://ctdbase.org/detail.go?type=gene&acc=166614,,,166614,DCLK2,9606,Homo sapiens (human),"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
28,1758762,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634,DCN,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DCN mRNA",,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
29,1758912,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142,DCUN1D4,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCUN1D4 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCUN1D4 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCUN1D4 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCUN1D4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
30,1758913,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641,DCX,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DCX mRNA",,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
31,1758914,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641,DCX,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DCX protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
32,1758915,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,51202,DDX47,https://ctdbase.org/detail.go?type=gene&acc=51202,,,51202,DDX47,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX47 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
33,1758916,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071,DERA,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DERA protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
34,1759025,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,6236,RRAD,https://ctdbase.org/detail.go?type=gene&acc=6236,,,6236,RRAD,9606,Homo sapiens (human),Senecionine results in increased expression of RRAD mRNA,,,PMID:26100227,https://www.ncbi.nlm.nih.gov/pubmed/26100227,26100227,,
35,1758024,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7167,TPI1,https://ctdbase.org/detail.go?type=gene&acc=7167,,,7167,TPI1,10116,Rattus norvegicus (Norway rat),Genistein results in increased expression of TPI1 mRNA,,,PMID:12075121,https://www.ncbi.nlm.nih.gov/pubmed/12075121,12075121,,
36,1758025,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,27010,TPK1,https://ctdbase.org/detail.go?type=gene&acc=27010,,,27010,TPK1,9606,Homo sapiens (human),Genistein results in decreased expression of TPK1 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
37,1758026,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168,TPM1,9606,Homo sapiens (human),Genistein results in decreased expression of TPM1 mRNA,,,PMID:20884965|PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/20884965|https://www.ncbi.nlm.nih.gov/pubmed/26865667,20884965|26865667,,
38,1758027,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7170,TPM3,https://ctdbase.org/detail.go?type=gene&acc=7170,,,7170,TPM3,9606,Homo sapiens (human),Genistein results in increased expression of TPM3 mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
39,1758028,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7173,TPO,https://ctdbase.org/detail.go?type=gene&acc=7173,,,7173,TPO,9606,Homo sapiens (human),Genistein results in decreased activity of TPO protein,,,PMID:21809831|PMID:31629072,https://www.ncbi.nlm.nih.gov/pubmed/21809831|https://www.ncbi.nlm.nih.gov/pubmed/31629072,21809831|31629072,,
40,1758227,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7173,TPO,https://ctdbase.org/detail.go?type=gene&acc=7173,,,7173,TPO,10116,Rattus norvegicus (Norway rat),Genistein results in decreased expression of TPO protein|genistein results in decreased expression of TPO mRNA,,,PMID:24793811,https://www.ncbi.nlm.nih.gov/pubmed/24793811,24793811,,
41,1758228,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7175,TPR,https://ctdbase.org/detail.go?type=gene&acc=7175,,,7175,TPR,9606,Homo sapiens (human),ESR1 promotes the reaction [genistein results in decreased expression of TPR protein]|genistein results in decreased expression of TPR protein,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
42,1758229,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7177,TPSAB1,https://ctdbase.org/detail.go?type=gene&acc=7177,,,7177,TPSAB1,10090,Mus musculus (house mouse),Genistein results in decreased expression of TPSAB1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
43,1758230,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,64499,TPSB2,https://ctdbase.org/detail.go?type=gene&acc=64499,,,64499,TPSB2,10090,Mus musculus (house mouse),Genistein results in decreased expression of TPSB2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
44,1758231,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,25823,TPSG1,https://ctdbase.org/detail.go?type=gene&acc=25823,,,25823,TPSG1,10090,Mus musculus (house mouse),Genistein results in decreased expression of TPSG1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
45,1758232,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7179,TPTE,https://ctdbase.org/detail.go?type=gene&acc=7179,,,7179,TPTE,10090,Mus musculus (house mouse),Genistein results in decreased expression of TPTE mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
46,1758233,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,22878,TRAPPC8,https://ctdbase.org/detail.go?type=gene&acc=22878,,,22878,TRAPPC8,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in decreased methylation of TRAPPC8 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
47,1758439,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7201,TRHR,https://ctdbase.org/detail.go?type=gene&acc=7201,,,7201,TRHR,10090,Mus musculus (house mouse),Genistein results in increased expression of TRHR mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
48,1758440,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761,TRIB3,9606,Homo sapiens (human),Genistein results in increased expression of TRIB3 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
49,1758441,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9865,TRIL,https://ctdbase.org/detail.go?type=gene&acc=9865,,,9865,TRIL,10090,Mus musculus (house mouse),Genistein results in increased expression of TRIL mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
50,1758442,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10626,TRIM16,https://ctdbase.org/detail.go?type=gene&acc=10626,,,10626,TRIM16,9606,Homo sapiens (human),Genistein results in decreased expression of TRIM16 mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
51,1758443,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,373,TRIM23,https://ctdbase.org/detail.go?type=gene&acc=373,,,373,TRIM23,10090,Mus musculus (house mouse),Genistein results in decreased expression of TRIM23 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
52,1758444,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706,TRIM25,9606,Homo sapiens (human),Genistein results in increased expression of TRIM25 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
53,1758445,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,244183,TRIM30B,https://ctdbase.org/detail.go?type=gene&acc=244183,,,244183,Trim30b,10090,Mus musculus (house mouse),Genistein results in decreased expression of TRIM30B mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
54,1758619,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,389558,FAM180A,https://ctdbase.org/detail.go?type=gene&acc=389558,,,389558,FAM180A,9606,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM180A mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
55,1758620,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,90050,FAM181A,https://ctdbase.org/detail.go?type=gene&acc=90050,,,90050,FAM181A,10090,Mus musculus (house mouse),Genistein results in decreased expression of FAM181A mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
56,1758621,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,27146,FAM184B,https://ctdbase.org/detail.go?type=gene&acc=27146,,,27146,FAM184B,10090,Mus musculus (house mouse),Genistein results in increased expression of FAM184B mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
57,1758622,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,76426,FAM209,https://ctdbase.org/detail.go?type=gene&acc=76426,,,76426,Fam209,10090,Mus musculus (house mouse),Genistein results in increased expression of FAM209 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
58,1758623,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,54757,FAM20A,https://ctdbase.org/detail.go?type=gene&acc=54757,,,54757,FAM20A,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of FAM20A gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
59,1758624,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9917,FAM20B,https://ctdbase.org/detail.go?type=gene&acc=9917,,,9917,FAM20B,10090,Mus musculus (house mouse),Genistein results in decreased expression of FAM20B mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
60,1758625,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,56975,FAM20C,https://ctdbase.org/detail.go?type=gene&acc=56975,,,56975,FAM20C,10090,Mus musculus (house mouse),Genistein results in increased expression of FAM20C mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
61,1758626,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,116151,FAM210B,https://ctdbase.org/detail.go?type=gene&acc=116151,,,116151,FAM210B,9606,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
62,1758627,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,132720,FAM241A,https://ctdbase.org/detail.go?type=gene&acc=132720,,,132720,FAM241A,9606,Homo sapiens (human),Genistein affects the expression of FAM241A mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
63,1758628,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,132720,FAM241A,https://ctdbase.org/detail.go?type=gene&acc=132720,,,132720,FAM241A,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of FAM241A gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
64,1758846,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2176,FANCC,https://ctdbase.org/detail.go?type=gene&acc=2176,,,2176,FANCC,9606,Homo sapiens (human),Genistein results in decreased expression of FANCC mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
65,1758847,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,55215,FANCI,https://ctdbase.org/detail.go?type=gene&acc=55215,,,55215,FANCI,7955,Danio rerio (zebrafish),Genistein results in increased expression of FANCI mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
66,1758848,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,55215,FANCI,https://ctdbase.org/detail.go?type=gene&acc=55215,,,55215,FANCI,9606,Homo sapiens (human),Genistein results in increased expression of FANCI mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
67,1758849,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,55711,FAR2,https://ctdbase.org/detail.go?type=gene&acc=55711,,,55711,FAR2,10090,Mus musculus (house mouse),Genistein results in decreased expression of FAR2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
68,1758850,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,10160,FARP1,https://ctdbase.org/detail.go?type=gene&acc=10160,,,10160,FARP1,9606,Homo sapiens (human),Genistein results in increased expression of FARP1 mRNA,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
69,1758029,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720,GLB1,9606,Homo sapiens (human),Wogonin results in increased expression of GLB1 protein,,,PMID:32671444,https://www.ncbi.nlm.nih.gov/pubmed/32671444,32671444,,
70,1758030,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932,GSK3B,9606,Homo sapiens (human),Wogonin results in increased expression of GSK3B protein|wogonin results in decreased expression of GSK3B protein modified form,,,PMID:23872260,https://www.ncbi.nlm.nih.gov/pubmed/23872260,23872260,,
71,1758031,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014,H2AX,9606,Homo sapiens (human),Wogonin inhibits the reaction [benzo(a)pyrene results in increased expression of H2AX protein],,,PMID:37515497,https://www.ncbi.nlm.nih.gov/pubmed/37515497,37515497,,
72,1758032,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014,H2AX,9606,Homo sapiens (human),Wogonin results in increased expression of H2AX protein,,,PMID:32671444,https://www.ncbi.nlm.nih.gov/pubmed/32671444,32671444,,
73,1758033,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091,HIF1A,10090,Mus musculus (house mouse),"Wogonin inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of HIF1A protein]",,,PMID:26213241,https://www.ncbi.nlm.nih.gov/pubmed/26213241,26213241,,
74,1758034,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,9,NAT1,https://ctdbase.org/detail.go?type=gene&acc=9,,,9,NAT1,9606,Homo sapiens (human),Wogonin results in decreased expression of NAT1 mrna|wogonin results in decreased expression of NAT1 protein,,,PMID:15816529,https://www.ncbi.nlm.nih.gov/pubmed/15816529,15816529,,
75,1758747,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,10090,Mus musculus (house mouse),Wogonin inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK8 protein],,,PMID:23362215,https://www.ncbi.nlm.nih.gov/pubmed/23362215,23362215,,
76,1758748,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601,MAPK9,10090,Mus musculus (house mouse),Wogonin inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK9 protein],,,PMID:23362215,https://www.ncbi.nlm.nih.gov/pubmed/23362215,23362215,,
77,1758749,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288,MKI67,9606,Homo sapiens (human),Wogonin results in decreased expression of MKI67 protein,,,PMID:32671444,https://www.ncbi.nlm.nih.gov/pubmed/32671444,32671444,,
78,1758750,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313,MMP2,9606,Homo sapiens (human),Wogonin results in decreased expression of and results in decreased activity of MMP2 protein,,,PMID:21295103,https://www.ncbi.nlm.nih.gov/pubmed/21295103,21295103,,
79,1758751,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Wogonin results in decreased expression of and results in decreased activity of MMP9 protein|wogonin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of and results in increased activity of MMP9 protein],,,PMID:21295103,https://www.ncbi.nlm.nih.gov/pubmed/21295103,21295103,,
80,1758752,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,10116,Rattus norvegicus (Norway rat),Wogonin inhibits the reaction [[lipopolysaccharides co-treated with tetradecanoylphorbol acetate] results in increased activity of MMP9 protein],,,PMID:14700523,https://www.ncbi.nlm.nih.gov/pubmed/14700523,14700523,,
81,1758753,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,4968,OGG1,https://ctdbase.org/detail.go?type=gene&acc=4968,,,4968,OGG1,10090,Mus musculus (house mouse),Wogonin inhibits the reaction [etoposide results in decreased expression of OGG1 mrna],,,PMID:23872129,https://www.ncbi.nlm.nih.gov/pubmed/23872129,23872129,,
82,1758754,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315,PKM,9606,Homo sapiens (human),Wogonin inhibits the reaction [PKM protein results in increased metabolism of phosphoenolpyruvate],,,PMID:25388478,https://www.ncbi.nlm.nih.gov/pubmed/25388478,25388478,,
83,1758755,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10116,Rattus norvegicus (Norway rat),Wogonin inhibits the reaction [cisplatin results in decreased expression of PPARG protein],,,PMID:31103702,https://www.ncbi.nlm.nih.gov/pubmed/31103702,31103702,,
84,1758756,5281703,Comparative Toxicogenomics Database (CTD),Wogonin,C085514,wogonin,https://ctdbase.org/detail.go?type=chem&acc=C085514,5584,PRKCI,https://ctdbase.org/detail.go?type=gene&acc=5584,,,5584,PRKCI,9606,Homo sapiens (human),Wogonin inhibits the reaction [tetradecanoylphorbol acetate results in increased localization of PRKCI protein],,,PMID:21295103,https://www.ncbi.nlm.nih.gov/pubmed/21295103,21295103,,
85,1757939,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999,CDH1,9606,Homo sapiens (human),Pterostilbene results in increased expression of CDH1 protein,,,PMID:23921149,https://www.ncbi.nlm.nih.gov/pubmed/23921149,23921149,,
86,1757940,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999,CDH1,10090,Mus musculus (house mouse),Pterostilbene inhibits the reaction [azoxymethane results in decreased expression of CDH1 protein],,,PMID:20681671,https://www.ncbi.nlm.nih.gov/pubmed/20681671,20681671,,
87,1757941,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017,CDK2,10116,Rattus norvegicus (Norway rat),Pterostilbene results in decreased expression of CDK2 protein,,,PMID:20398797,https://www.ncbi.nlm.nih.gov/pubmed/20398797,20398797,,
88,1757942,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019,CDK4,10116,Rattus norvegicus (Norway rat),Pterostilbene results in decreased expression of CDK4 protein,,,PMID:20398797,https://www.ncbi.nlm.nih.gov/pubmed/20398797,20398797,,
89,1757943,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Pterostilbene inhibits the reaction [ethanol results in increased expression of CDKN1A protein]|ccn1 protein inhibits the reaction [pterostilbene inhibits the reaction [ethanol results in increased expression of CDKN1A protein]]|sesn2 protein promotes the reaction [pterostilbene inhibits the reaction [ethanol results in decreased expression of CDKN1A protein]],,,PMID:34405320,https://www.ncbi.nlm.nih.gov/pubmed/34405320,34405320,,
90,1757934,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401,CRP,10090,Mus musculus (house mouse),Cyclosporine results in decreased expression of CRP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
91,1757935,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401,CRP,10116,Rattus norvegicus (Norway rat),Cyclosporine inhibits the reaction [thioctic acid inhibits the reaction [acetic acid results in increased expression of CRP protein]],,,PMID:26276312,https://www.ncbi.nlm.nih.gov/pubmed/26276312,26276312,,
92,1757936,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401,CRP,10116,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of CRP mRNA,,,PMID:24971338,https://www.ncbi.nlm.nih.gov/pubmed/24971338,24971338,,
93,1757937,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,200186,CRTC2,https://ctdbase.org/detail.go?type=gene&acc=200186,,,200186,CRTC2,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRTC2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
94,1757938,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,64784,CRTC3,https://ctdbase.org/detail.go?type=gene&acc=64784,,,64784,CRTC3,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRTC3 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
95,1758133,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1407,CRY1,https://ctdbase.org/detail.go?type=gene&acc=1407,,,1407,CRY1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CRY1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
96,1758134,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1407,CRY1,https://ctdbase.org/detail.go?type=gene&acc=1407,,,1407,CRY1,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRY1 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
97,1758135,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1408,CRY2,https://ctdbase.org/detail.go?type=gene&acc=1408,,,1408,CRY2,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRY2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
98,1758136,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1409,CRYAA,https://ctdbase.org/detail.go?type=gene&acc=1409,,,1409,CRYAA,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CRYAA mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
99,1758137,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1409,CRYAA,https://ctdbase.org/detail.go?type=gene&acc=1409,,,1409,CRYAA,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRYAA mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
100,1758138,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410,CRYAB,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CRYAB mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
101,1758139,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410,CRYAB,10116,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of CRYAB protein|cyclosporine affects the localization of CRYAB protein,,,PMID:19540300,https://www.ncbi.nlm.nih.gov/pubmed/19540300,19540300,,
102,1758140,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410,CRYAB,10116,Rattus norvegicus (Norway rat),Cyclosporine results in increased expression of CRYAB protein,,,PMID:21073006,https://www.ncbi.nlm.nih.gov/pubmed/21073006,21073006,,
103,1758141,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1412,CRYBA2,https://ctdbase.org/detail.go?type=gene&acc=1412,,,1412,CRYBA2,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRYBA2 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
104,1758142,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,202,CRYBG1,https://ctdbase.org/detail.go?type=gene&acc=202,,,202,CRYBG1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CRYBG1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
105,1758143,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,202,CRYBG1,https://ctdbase.org/detail.go?type=gene&acc=202,,,202,CRYBG1,9606,Homo sapiens (human),Cyclosporine results in increased expression of CRYBG1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
106,1758770,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5530,PPP3CA,https://ctdbase.org/detail.go?type=gene&acc=5530,,,5530,PPP3CA,9606,Homo sapiens (human),Cyclosporine results in decreased activity of [PPP3CA protein binds to PPP3R1 protein],,,PMID:19880376,https://www.ncbi.nlm.nih.gov/pubmed/19880376,19880376,,
107,1758771,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5532,PPP3CB,https://ctdbase.org/detail.go?type=gene&acc=5532,,,5532,PPP3CB,9606,Homo sapiens (human),Cyclosporine inhibits the reaction [bisphenol F results in increased expression of PPP3CB protein],,,PMID:34023961,https://www.ncbi.nlm.nih.gov/pubmed/34023961,34023961,,
108,1758772,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5532,PPP3CB,https://ctdbase.org/detail.go?type=gene&acc=5532,,,5532,PPP3CB,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PPP3CB mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
109,1758773,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5532,PPP3CB,https://ctdbase.org/detail.go?type=gene&acc=5532,,,5532,PPP3CB,9606,Homo sapiens (human),Cyclosporine results in decreased activity of PPP3CB protein,,,PMID:30335591,https://www.ncbi.nlm.nih.gov/pubmed/30335591,30335591,,
110,1758851,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55790,CSGALNACT1,https://ctdbase.org/detail.go?type=gene&acc=55790,,,55790,CSGALNACT1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CSGALNACT1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
111,1758852,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55454,CSGALNACT2,https://ctdbase.org/detail.go?type=gene&acc=55454,,,55454,CSGALNACT2,9606,Homo sapiens (human),Cyclosporine results in increased expression of CSGALNACT2 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
112,1758853,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,751071,CSKMT,https://ctdbase.org/detail.go?type=gene&acc=751071,,,751071,CSKMT,9606,Homo sapiens (human),Cyclosporine results in increased expression of CSKMT mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
113,1758854,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,114788,CSMD3,https://ctdbase.org/detail.go?type=gene&acc=114788,,,114788,CSMD3,9606,Homo sapiens (human),Cyclosporine results in decreased expression of CSMD3 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
114,1758855,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1452,CSNK1A1,https://ctdbase.org/detail.go?type=gene&acc=1452,,,1452,CSNK1A1,9606,Homo sapiens (human),Cyclosporine results in increased expression of CSNK1A1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
115,1758856,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453,CSNK1D,9606,Homo sapiens (human),Cyclosporine results in increased expression of CSNK1D mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
116,1759019,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5538,PPT1,https://ctdbase.org/detail.go?type=gene&acc=5538,,,5538,PPT1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PPT1 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
117,1759020,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9374,PPT2,https://ctdbase.org/detail.go?type=gene&acc=9374,,,9374,PPT2,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PPT2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
118,1759021,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9374,PPT2,https://ctdbase.org/detail.go?type=gene&acc=9374,,,9374,PPT2,10090,Mus musculus (house mouse),Cyclosporine results in increased expression of PPT2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
119,1759022,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84279,PRADC1,https://ctdbase.org/detail.go?type=gene&acc=84279,,,84279,PRADC1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PRADC1 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
120,1759023,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,157285,PRAG1,https://ctdbase.org/detail.go?type=gene&acc=157285,,,157285,PRAG1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PRAG1 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
121,1759024,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,157285,PRAG1,https://ctdbase.org/detail.go?type=gene&acc=157285,,,157285,PRAG1,9606,Homo sapiens (human),Cyclosporine results in increased expression of PRAG1 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
122,1758455,5284507,Toxin and Toxin Target Database (T3DB),trans-Nerolidol,T3D4929,Nerolidol,http://www.t3db.ca/toxins/T3D4929,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099,ESR1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
123,1758456,5284507,Toxin and Toxin Target Database (T3DB),trans-Nerolidol,T3D4929,Nerolidol,http://www.t3db.ca/toxins/T3D4929,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856,NR1I2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
124,1758457,5284537,Comparative Toxicogenomics Database (CTD),Cyproterone,D003534,Cyproterone,https://ctdbase.org/detail.go?type=chem&acc=D003534,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367,AR,9606,Homo sapiens (human),AR protein mutant form results in decreased susceptibility to cyproterone,,,PMID:28757136,https://www.ncbi.nlm.nih.gov/pubmed/28757136,28757136,,
125,1758458,5284537,Comparative Toxicogenomics Database (CTD),Cyproterone,D003534,Cyproterone,https://ctdbase.org/detail.go?type=chem&acc=D003534,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588,CYP19A1,9606,Homo sapiens (human),[cyproterone co-treated with albuterol] results in decreased expression of CYP19A1,,,PMID:17822730,https://www.ncbi.nlm.nih.gov/pubmed/17822730,17822730,,
126,1758459,5284537,Comparative Toxicogenomics Database (CTD),Cyproterone,D003534,Cyproterone,https://ctdbase.org/detail.go?type=chem&acc=D003534,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088,Cyp2b10,10090,Mus musculus (house mouse),Cyproterone results in increased expression of CYP2B10 mRNA,,,PMID:7771797,https://www.ncbi.nlm.nih.gov/pubmed/7771797,7771797,,
127,1758460,5284537,Comparative Toxicogenomics Database (CTD),Cyproterone,D003534,Cyproterone,https://ctdbase.org/detail.go?type=chem&acc=D003534,13094,CYP2B9,https://ctdbase.org/detail.go?type=gene&acc=13094,,,13094,Cyp2b9,10090,Mus musculus (house mouse),Cyproterone results in increased expression of CYP2B9 mRNA,,,PMID:7771797,https://www.ncbi.nlm.nih.gov/pubmed/7771797,7771797,,
128,1758906,5284584,ChEMBL,Loracarbef monohydrate,CHEMBL1200610,LORACARBEF,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200610/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
129,1758907,5284584,ChEMBL,Loracarbef monohydrate,CHEMBL1200610,LORACARBEF,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200610/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
130,1758908,5284584,ChEMBL,Loracarbef monohydrate,CHEMBL1200610,LORACARBEF,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200610/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
131,1758909,5284584,ChEMBL,Loracarbef monohydrate,CHEMBL1200610,LORACARBEF,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200610/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
132,1758910,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,7295,TXN,https://ctdbase.org/detail.go?type=gene&acc=7295,,,7295,TXN,10116,Rattus norvegicus (Norway rat),Naloxone results in increased expression of TXN mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
133,1758911,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,7364,UGT2B7,https://ctdbase.org/detail.go?type=gene&acc=7364,,,7364,UGT2B7,9606,Homo sapiens (human),UGT2B7 protein affects the metabolism of naloxone,,,PMID:15286053,https://www.ncbi.nlm.nih.gov/pubmed/15286053,15286053,,
134,1758446,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein]|butylated hydroxyanisole inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
135,1758447,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),U 0126 inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein]|acetylcysteine inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein]|bi D1870 inhibits the reaction [fenretinide results in increased phosphorylation of MAPK3 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,
136,1758448,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),Fenretinide results in increased phosphorylation of MAPK3 protein,,,PMID:16407847|PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/16407847|https://www.ncbi.nlm.nih.gov/pubmed/25246272,16407847|25246272,,
137,1758449,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),[IL24 protein co-treated with fenretinide] results in increased phosphorylation of MAPK3 protein,,,PMID:15580305,https://www.ncbi.nlm.nih.gov/pubmed/15580305,15580305,,
138,1758450,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5597,MAPK6,https://ctdbase.org/detail.go?type=gene&acc=5597,,,5597,MAPK6,10090,Mus musculus (house mouse),Fenretinide results in decreased expression of MAPK6 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
139,1758451,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5598,MAPK7,https://ctdbase.org/detail.go?type=gene&acc=5598,,,5598,MAPK7,9606,Homo sapiens (human),[IL24 protein co-treated with fenretinide] results in increased phosphorylation of MAPK7 protein,,,PMID:15580305,https://www.ncbi.nlm.nih.gov/pubmed/15580305,15580305,,
140,1758452,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,9606,Homo sapiens (human),Fenretinide results in increased activity of MAPK8 protein|mapk8 protein promotes the reaction [fenretinide results in increased cleavage of PARP1 protein]|butylated hydroxyanisole inhibits the reaction [fenretinide results in increased phosphorylation of MAPK8 protein]|mapk8 protein promotes the reaction [fenretinide results in increased phosphorylation of JUN protein]|fenretinide results in increased phosphorylation of MAPK8 protein,,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
141,1758453,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,9606,Homo sapiens (human),[IL24 protein co-treated with fenretinide] results in increased phosphorylation of MAPK8 protein,,,PMID:15580305,https://www.ncbi.nlm.nih.gov/pubmed/15580305,15580305,,
142,1758454,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601,MAPK9,9606,Homo sapiens (human),[IL24 protein co-treated with fenretinide] results in increased phosphorylation of MAPK9 protein,,,PMID:15580305,https://www.ncbi.nlm.nih.gov/pubmed/15580305,15580305,,
143,1758144,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788,DNMT3A,10090,Mus musculus (house mouse),Morphine affects the expression of DNMT3A mRNA,,,PMID:33891991,https://www.ncbi.nlm.nih.gov/pubmed/33891991,33891991,,
144,1758145,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1789,DNMT3B,https://ctdbase.org/detail.go?type=gene&acc=1789,,,1789,DNMT3B,10090,Mus musculus (house mouse),Morphine affects the expression of DNMT3B mRNA,,,PMID:33891991,https://www.ncbi.nlm.nih.gov/pubmed/33891991,33891991,,
145,1758347,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813,DRD2,10116,Rattus norvegicus (Norway rat),Morphine results in decreased expression of DRD2 mRNA,,,PMID:15183518,https://www.ncbi.nlm.nih.gov/pubmed/15183518,15183518,,
146,1758348,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1815,DRD4,https://ctdbase.org/detail.go?type=gene&acc=1815,,,1815,DRD4,10116,Rattus norvegicus (Norway rat),Morphine results in increased expression of DRD4 mRNA,,,PMID:15183518,https://www.ncbi.nlm.nih.gov/pubmed/15183518,15183518,,
147,1758349,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,57453,DSCAML1,https://ctdbase.org/detail.go?type=gene&acc=57453,,,57453,DSCAML1,10090,Mus musculus (house mouse),Morphine results in increased expression of DSCAML1 mRNA,,,PMID:20144693,https://www.ncbi.nlm.nih.gov/pubmed/20144693,20144693,,
148,1758350,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848,DUSP6,10090,Mus musculus (house mouse),Morphine deficiency results in increased expression of DUSP6 mRNA,,,PMID:27126842,https://www.ncbi.nlm.nih.gov/pubmed/27126842,27126842,,
149,1758351,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848,DUSP6,10090,Mus musculus (house mouse),Morphine results in increased expression of DUSP6 mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
150,1758352,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1778,DYNC1H1,https://ctdbase.org/detail.go?type=gene&acc=1778,,,1778,DYNC1H1,10090,Mus musculus (house mouse),Morphine results in decreased expression of DYNC1H1 mRNA,,,PMID:21178816,https://www.ncbi.nlm.nih.gov/pubmed/21178816,21178816,,
151,1758353,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1961,EGR4,https://ctdbase.org/detail.go?type=gene&acc=1961,,,1961,EGR4,10090,Mus musculus (house mouse),"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [morphine results in increased expression of EGR4 mrna]|egr4 protein affects the susceptibility to morphine|[morphine results in increased activity of ELK1 protein] which results in increased expression of EGR4 mrna|morphine results in increased expression of EGR4 mRNA",,,PMID:22454534,https://www.ncbi.nlm.nih.gov/pubmed/22454534,22454534,,
152,1758354,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938,EHD1,10116,Rattus norvegicus (Norway rat),Morphine deficiency inhibits the reaction [morphine results in decreased expression of EHD1 protein]|morphine results in decreased expression of EHD1 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
153,1758355,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,79813,EHMT1,https://ctdbase.org/detail.go?type=gene&acc=79813,,,79813,EHMT1,10090,Mus musculus (house mouse),Morphine affects the expression of EHMT1 mRNA,,,PMID:33891991,https://www.ncbi.nlm.nih.gov/pubmed/33891991,33891991,,
154,1758548,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,1984,EIF5A,https://ctdbase.org/detail.go?type=gene&acc=1984,,,1984,EIF5A,9606,Homo sapiens (human),Morphine results in increased expression of EIF5A mRNA,,,PMID:19397953,https://www.ncbi.nlm.nih.gov/pubmed/19397953,19397953,,
155,1758549,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002,ELK1,10090,Mus musculus (house mouse),ELK1 protein affects the susceptibility to morphine|[morphine results in increased activity of ELK1 protein] which results in increased expression of EGR4 mrna|morphine results in increased activity of ELK1 protein,,,PMID:22454534,https://www.ncbi.nlm.nih.gov/pubmed/22454534,22454534,,
156,1758550,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,24139,EML2,https://ctdbase.org/detail.go?type=gene&acc=24139,,,24139,EML2,10116,Rattus norvegicus (Norway rat),Morphine results in increased expression of EML2 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
157,1758551,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,5169,ENPP3,https://ctdbase.org/detail.go?type=gene&acc=5169,,,5169,ENPP3,10116,Rattus norvegicus (Norway rat),Morphine results in increased expression of ENPP3 protein,,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
158,1758552,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053,EPHX2,10090,Mus musculus (house mouse),Morphine results in increased expression of EPHX2 mRNA,,,PMID:21178816,https://www.ncbi.nlm.nih.gov/pubmed/21178816,21178816,,
159,1758553,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,23071,ERP44,https://ctdbase.org/detail.go?type=gene&acc=23071,,,23071,ERP44,10090,Mus musculus (house mouse),Morphine results in increased expression of ERP44 mRNA,,,PMID:21178816,https://www.ncbi.nlm.nih.gov/pubmed/21178816,21178816,,
160,1758554,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146,EZH2,10090,Mus musculus (house mouse),Morphine affects the expression of EZH2 mRNA,,,PMID:33891991,https://www.ncbi.nlm.nih.gov/pubmed/33891991,33891991,,
161,1758555,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146,EZH2,10116,Rattus norvegicus (Norway rat),Morphine promotes the reaction [EZH2 protein binds to BDNF promoter],,,PMID:25643298,https://www.ncbi.nlm.nih.gov/pubmed/25643298,25643298,,
162,1758556,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147,F2,10116,Rattus norvegicus (Norway rat),Morphine results in increased expression of F2 protein|morphine deficiency affects the reaction [morphine results in increased expression of F2 protein],,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
163,1758741,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355,FAS,9606,Homo sapiens (human),Morphine results in increased expression of FAS protein,,,PMID:16529824,https://www.ncbi.nlm.nih.gov/pubmed/16529824,16529824,,
164,1758742,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103,Fasl,10090,Mus musculus (house mouse),[FAS protein binds to FASL protein] affects the reaction [morphine results in increased expression of IL4 protein]|morphine results in increased expression of FASL mRNA,,,PMID:16210602,https://www.ncbi.nlm.nih.gov/pubmed/16210602,16210602,,
165,1758743,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,54751,FBLIM1,https://ctdbase.org/detail.go?type=gene&acc=54751,,,54751,FBLIM1,10116,Rattus norvegicus (Norway rat),Morphine results in increased expression of FBLIM1 protein|morphine deficiency affects the reaction [morphine results in increased expression of FBLIM1 protein],,,PMID:23056601,https://www.ncbi.nlm.nih.gov/pubmed/23056601,23056601,,
166,1758744,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2200,FBN1,https://ctdbase.org/detail.go?type=gene&acc=2200,,,2200,FBN1,10090,Mus musculus (house mouse),Morphine results in decreased expression of FBN1 mRNA,,,PMID:21178816,https://www.ncbi.nlm.nih.gov/pubmed/21178816,21178816,,
167,1758745,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2243,FGA,https://ctdbase.org/detail.go?type=gene&acc=2243,,,2243,FGA,10116,Rattus norvegicus (Norway rat),Morphine affects the secretion of FGA protein modified form,,,PMID:24855564,https://www.ncbi.nlm.nih.gov/pubmed/24855564,24855564,,
168,1758746,5288826,Comparative Toxicogenomics Database (CTD),Morphine,D009020,Morphine,https://ctdbase.org/detail.go?type=chem&acc=D009020,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247,FGF2,9606,Homo sapiens (human),Morphine results in decreased secretion of FGF2 protein|naloxone inhibits the reaction [morphine results in decreased secretion of FGF2 protein]|oprm1 protein affects the reaction [morphine results in decreased secretion of FGF2 protein],,,PMID:20564181,https://www.ncbi.nlm.nih.gov/pubmed/20564181,20564181,,
169,1758683,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095217,Fibroblast growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095217/,P11362,Fibroblast growth factor receptor 1,2260,FGFR1,9606,Homo sapiens (human),Fibroblast growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
170,1758684,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095217,Fibroblast growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095217/,P21802,Fibroblast growth factor receptor 2,2263,FGFR2,9606,Homo sapiens (human),Fibroblast growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
171,1758685,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095217,Fibroblast growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095217/,P22455,Fibroblast growth factor receptor 4,2264,FGFR4,9606,Homo sapiens (human),Fibroblast growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
172,1758686,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095217,Fibroblast growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095217/,P22607,Fibroblast growth factor receptor 3,2261,FGFR3,9606,Homo sapiens (human),Fibroblast growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
173,1758687,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095189,Platelet-derived growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095189/,P09619,Platelet-derived growth factor receptor beta,5159,PDGFRB,9606,Homo sapiens (human),Platelet-derived growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
174,1758688,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL2095189,Platelet-derived growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095189/,P16234,Platelet-derived growth factor receptor alpha,5156,PDGFRA,9606,Homo sapiens (human),Platelet-derived growth factor receptor inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
175,1758689,5329099,ChEMBL,Orantinib,CHEMBL274654,ORANTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL274654/,CHEMBL279,Vascular endothelial growth factor receptor 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL279/,P35968,Vascular endothelial growth factor receptor 2,3791,KDR,9606,Homo sapiens (human),Vascular endothelial growth factor receptor 2 inhibitor,,,PMID:10945623,https://www.ncbi.nlm.nih.gov/pubmed/10945623,10945623,,
176,1758690,5329099,Drug Gene Interaction database (DGIdb),Orantinib,,ORANTINIB,https://www.dgidb.org/drugs/ncit:C1884,,PDGFRB,https://www.dgidb.org/genes/hgnc:8804,,,5159,PDGFRB,9606,Homo sapiens (human),Inhibitor,,,,,,,
177,1758691,5329099,Drug Gene Interaction database (DGIdb),Orantinib,,ORANTINIB,https://www.dgidb.org/drugs/ncit:C1884,,FGFR1,https://www.dgidb.org/genes/hgnc:3688,,,2260,FGFR1,9606,Homo sapiens (human),Inhibitor,,,,,,,
178,1758692,5329099,Drug Gene Interaction database (DGIdb),Orantinib,,ORANTINIB,https://www.dgidb.org/drugs/ncit:C1884,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791,KDR,9606,Homo sapiens (human),Inhibitor,,,,,,,
179,1758958,5329102,Drug Gene Interaction database (DGIdb),Sunitinib,,SUNITINIB,https://www.dgidb.org/drugs/rxcui:357977,,BAP1,https://www.dgidb.org/genes/hgnc:950,,,8314,BAP1,9606,Homo sapiens (human),,,,,,,,
180,1758959,5329338,Therapeutic Target Database (TTD),Benzimidazole 2,D0U3ZP,5-(4-Methoxy-phenyl)-1-phenyl-1H-benzoimidazole,https://idrblab.net/ttd/data/drug/details/D0U3ZP,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791,KDR,9606,Homo sapiens (human),Inhibitor,,,,,,,
181,1758960,5329369,Therapeutic Target Database (TTD),Benzoannulenone 1,D00MCJ,6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one,https://idrblab.net/ttd/data/drug/details/D00MCJ,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791,KDR,9606,Homo sapiens (human),Inhibitor,,,,,,,
182,1758961,5329370,Therapeutic Target Database (TTD),,D07QMC,3-Benzimidazol-2-ylhydroquinolin-2-one,https://idrblab.net/ttd/data/drug/details/D07QMC,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791,KDR,9606,Homo sapiens (human),Inhibitor,,,,,,,
183,1758962,5329370,Therapeutic Target Database (TTD),,D07QMC,3-Benzimidazol-2-ylhydroquinolin-2-one,https://idrblab.net/ttd/data/drug/details/D07QMC,T59102,Platelet-derived growth factor receptor beta (PDGFRB),https://idrblab.net/ttd/data/target/details/T59102,P09619,Platelet-derived growth factor receptor beta,5159,PDGFRB,9606,Homo sapiens (human),Inhibitor,,,,,,,
184,1758963,5329370,Therapeutic Target Database (TTD),,D07QMC,3-Benzimidazol-2-ylhydroquinolin-2-one,https://idrblab.net/ttd/data/drug/details/D07QMC,T47101,Fibroblast growth factor receptor 1 (FGFR1),https://idrblab.net/ttd/data/target/details/T47101,P11362,Fibroblast growth factor receptor 1,2260,FGFR1,9606,Homo sapiens (human),Inhibitor,,,,,,,
185,1758964,5329371,Therapeutic Target Database (TTD),2-Quinolinone deriv. 3,D0M9OF,3-(1H-Indol-2-yl)-1H-quinolin-2-one,https://idrblab.net/ttd/data/drug/details/D0M9OF,T80975,Vascular endothelial growth factor receptor 2 (KDR),https://idrblab.net/ttd/data/target/details/T80975,P35968,Vascular endothelial growth factor receptor 2,3791,KDR,9606,Homo sapiens (human),Inhibitor,,,,,,,
186,1758223,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0004979,Cytochrome c oxidase subunit 6B2,http://www.t3db.ca/biodb/bio_entities/BE0004979,Q6YFQ2,Cytochrome c oxidase subunit 6B2,125965,COX6B2,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
187,1758224,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0003990,Cytochrome c oxidase subunit 6C,http://www.t3db.ca/biodb/bio_entities/BE0003990,P09669,Cytochrome c oxidase subunit 6C,1345,COX6C,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
188,1758225,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003996,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",1346,COX7A1,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
189,1758226,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0004983,"Cytochrome c oxidase subunit 7A2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004983,P14406,"Cytochrome c oxidase subunit 7A2, mitochondrial",1347,COX7A2,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
190,1758345,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0000820,Epididymal secretory glutathione peroxidase,http://www.t3db.ca/biodb/bio_entities/BE0000820,O75715,Epididymal secretory glutathione peroxidase,2880,GPX5,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
191,1758346,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0005057,Extracellular superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0005057,P08294,Extracellular superoxide dismutase [Cu-Zn],6649,SOD3,9606,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
192,1758629,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882,GPX7,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
193,1758763,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879,GPX4,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
194,1758764,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0000672,Potassium voltage-gated channel subfamily KQT member 1,http://www.t3db.ca/biodb/bio_entities/BE0000672,P51787,Potassium voltage-gated channel subfamily KQT member 1,3784,KCNQ1,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
195,1758765,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0000897,Potassium voltage-gated channel subfamily KQT member 2,http://www.t3db.ca/biodb/bio_entities/BE0000897,O43526,Potassium voltage-gated channel subfamily KQT member 2,3785,KCNQ2,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
196,1758766,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0002398,Potassium voltage-gated channel subfamily KQT member 3,http://www.t3db.ca/biodb/bio_entities/BE0002398,O43525,Potassium voltage-gated channel subfamily KQT member 3,3786,KCNQ3,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
197,1758767,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0002399,Potassium voltage-gated channel subfamily KQT member 4,http://www.t3db.ca/biodb/bio_entities/BE0002399,P56696,Potassium voltage-gated channel subfamily KQT member 4,9132,KCNQ4,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
198,1758768,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0002400,Potassium voltage-gated channel subfamily KQT member 5,http://www.t3db.ca/biodb/bio_entities/BE0002400,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,56479,KCNQ5,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
199,1758769,6093184,Toxin and Toxin Target Database (T3DB),Bariumcyanid,T3D1103,Barium cyanide,http://www.t3db.ca/toxins/T3D1103,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869,GPX8,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
200,1758965,6387197,Toxin and Toxin Target Database (T3DB),Antimony sulfide,T3D1886,Triantimony disulfide,http://www.t3db.ca/toxins/T3D1886,BE0000810,Glutathione S-transferase Mu 3,http://www.t3db.ca/biodb/bio_entities/BE0000810,P21266,Glutathione S-transferase Mu 3,2947,GSTM3,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
201,1758966,6387197,Toxin and Toxin Target Database (T3DB),Antimony sulfide,T3D1886,Triantimony disulfide,http://www.t3db.ca/toxins/T3D1886,BE0000812,Glutathione S-transferase Mu 4,http://www.t3db.ca/biodb/bio_entities/BE0000812,Q03013,Glutathione S-transferase Mu 4,2948,GSTM4,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
202,1758967,6387197,Toxin and Toxin Target Database (T3DB),Antimony sulfide,T3D1886,Triantimony disulfide,http://www.t3db.ca/toxins/T3D1886,BE0002285,Glutathione S-transferase Mu 5,http://www.t3db.ca/biodb/bio_entities/BE0002285,P46439,Glutathione S-transferase Mu 5,2949,GSTM5,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
203,1758968,6387197,Toxin and Toxin Target Database (T3DB),Antimony sulfide,T3D1886,Triantimony disulfide,http://www.t3db.ca/toxins/T3D1886,BE0000814,Glutathione S-transferase P,http://www.t3db.ca/biodb/bio_entities/BE0000814,P09211,Glutathione S-transferase P,2950,GSTP1,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
